These additional data, even if they still need to be completed, definitely contribute to adding more information about ULD-IL-6 when employed in MI, thus strengthening the current knowledge about the mode of action of 2LALERG®, previously reported in an in vivo model of allergic disease [28,33]. This evidence concerns the gene IL6 and allergic disease.